Cabot Corporation (CBT) Business Metric Overview - Stocknear

Cabot Corporation

NYSE: CBT · Real-Time Price · USD
80.99
0.60 (0.75%)
At close: Sep 04, 2025, 3:59 PM
81.02
0.04%
After-hours: Sep 04, 2025, 06:19 PM EDT

Cabot Revenue Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Mar 31, 2013 Dec 31, 2012
Performance Chemicals Revenue 311M 311M 322M 332M 311M 285M 306M 307M 326M 286M 338M 372M 360M 302M 284M 303M 294M 267M 459M 475M
Performance Chemicals Revenue Growth 0.00% -3.42% -3.01% +6.75% +9.12% -6.86% -0.33% -5.83% +13.99% -15.38% -9.14% +3.33% +19.21% +6.34% -6.27% +3.06% +10.11% -41.83% -3.37% n/a
Reinforcement Materials Revenue 594M 611M 644M 649M 676M 641M 624M 624M 672M 643M 700M 707M 627M 541M 493M 479M 434M 375M n/a n/a
Reinforcement Materials Revenue Growth -2.78% -5.12% -0.77% -3.99% +5.46% +2.72% 0.00% -7.14% +4.51% -8.14% -0.99% +12.76% +15.90% +9.74% +2.92% +10.37% +15.73% n/a n/a n/a

Revenue by Geography

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Americas Revenue 335M 334M 357M 368M 367M 342M 715M 380M 330M 404M 412M 378M 323M 307M 302M 267M 243M
Americas Revenue Growth +0.30% -6.44% -2.99% +0.27% +7.31% -52.17% +88.16% +15.15% -18.32% -1.94% +8.99% +17.03% +5.21% +1.66% +13.11% +9.88% n/a
Asia Pacific Revenue 337M 391M 389M 377M 375M 380M 719M 368M 399M 411M 402M 389M 384M 342M 324M 316M 282M
Asia Pacific Revenue Growth -13.81% +0.51% +3.18% +0.53% -1.32% -47.15% +95.38% -7.77% -2.92% +2.24% +3.34% +1.30% +12.28% +5.56% +2.53% +12.06% n/a
Emea Revenue 233M 197M 220M 236M 245M 204M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Emea Revenue Growth +18.27% -10.45% -6.78% -3.67% +20.10% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 62M 64M 66M 73M 68M 75M 67M 69M 58M 66M 60M 62M 51M 74M 71M 89M 68M 71M 61M 62M 52M 114M 64M 82M 65M 70M 73M 84M 74M 78M 69M 69M 63M 65M 63M 78M 64M 62M 71M 66M 67M 71M
Selling, General, and Administrative Revenue Growth -3.12% -3.03% -9.59% +7.35% -9.33% +11.94% -2.90% +18.97% -12.12% +10.00% -3.23% +21.57% -31.08% +4.23% -20.22% +30.88% -4.23% +16.39% -1.61% +19.23% -54.39% +78.12% -21.95% +26.15% -7.14% -4.11% -13.10% +13.51% -5.13% +13.04% 0.00% +9.52% -3.08% +3.17% -19.23% +21.88% +3.23% -12.68% +7.58% -1.49% -5.63% n/a
Research and Development Revenue 15M 15M 14M 17M 16M 15M 15M 14M 15M 15M 13M 14M 14M 14M 13M 15M 12M 15M 14M 16M 13M 14M 14M 13M 16M 15M 16M 18M 17M 16M 15M 16M 14M 14M 12M 13M 13M 11M 16M 14M 15M 14M
Research and Development Revenue Growth 0.00% +7.14% -17.65% +6.25% +6.67% 0.00% +7.14% -6.67% 0.00% +15.38% -7.14% 0.00% 0.00% +7.69% -13.33% +25.00% -20.00% +7.14% -12.50% +23.08% -7.14% 0.00% +7.69% -18.75% +6.67% -6.25% -11.11% +5.88% +6.25% +6.67% -6.25% +14.29% 0.00% +16.67% -7.69% 0.00% +18.18% -31.25% +14.29% -6.67% +7.14% n/a